AI assistant
Sending…
Cytek Biosciences, Inc. — Director's Dealing 2021
Jul 28, 2021
32966_dirs_2021-07-27_a8a694d5-0cfa-427d-a488-483314c2b694.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytek Biosciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2021-07-22
Reporting Person: Ball Jack (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-22 | Common Stock | P | 3000 | $17.00 | Acquired | 3000 | Direct |
Footnotes
F1: Reflects shares purchased from the underwriters in the Company's initial public offering.
More from Cytek Biosciences, Inc.
Board/Management Information
2026
Jun 25
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 16
Board/Management Information
2026
Jun 2
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 28
Call Transcript
2026
Mar 4
Call Transcript
2026
Feb 26
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26